Breathing pattern and central ventilatory drive in mild and moderate generalised myasthenia gravis

García Río, F; Prados, C; Díez Tejedor, E; Díaz Lobato, S; Alvarez-Sala, R; Villamor, J; Pino, J M
July 1994
Thorax;Jul1994, Vol. 49 Issue 7, p703
Academic Journal
No abstract available.


Related Articles

  • Diseases of the central nervous system. Havard, C.W.H. // British Medical Journal;10/18/1975, Vol. 4 Issue 5989, p152 

    Focuses on the diseases of the central nervous system. Information on myasthenia gravis; Treatment for myasthenia gravis; Risks of thymectomy.

  • Early Thymectomy for Myasthenia Gravis.  // British Medical Journal;8/2/1975, Vol. 3 Issue 5978, p262 

    Examines the effectiveness of thymectomy for myasthenia gravis in Great Britain. Innovations in ventilatory failure management; Benefits of thymectomy; Indications for thymectomy.

  • Mild Myasthenia Gravis.  // Saturday Evening Post;Jan/Feb85, Vol. 257 Issue 1, p107 

    Answers a question regarding mild myasthenia gravis. Hypoglycemia and weakness caused by the disease; Diagnosis.

  • Azathioprine/rituximab.  // Reactions Weekly;12/17/2011, Issue 1382, p10 

    The article describes five cases of various toxicities in patients with refractory generalised myasthenia gravis while receiving rituximab and azathioprine, which include pruritus, rigors and leucopenia.

  • Myasthenia gravis: Zentralnervóse Beteiligung und Schlaf. Stepansky, Robert; Happe, Svenja; Zeitlhofer, Josef // Somnologie;May2000, Vol. 4 Issue 2, p79 

    Presents a study that examined the involvement of the central nervous system (CRS) in myasthenia gravis (MG). Background on the disease; Possible mechanisms of CRS involvement in the disease; Benefits of a polysomnographic investigation for the detection of sleep-related breathing disorder in...

  • Pathogenesis and treatment of myasthenia gravis. Scadding, Glenis K.; Havard, C.W.H. // British Medical Journal (Clinical Research Edition);10/17/1981, Vol. 283 Issue 6298, p1008 

    Examines the pathogenesis and treatment of myasthenia gravis. Characterization of the disease; Evaluation of clinical patterns; Administration of symptomatic treatments.

  • Graded Response to Thymectomy in Children With Myasthenia Gravis. Tracy, Molly M.; McRae, Wes; Millichap, J. Gordon // Journal of Child Neurology;Apr2009, Vol. 24 Issue 4, p454 

    Response to thymectomy in children with juvenile myasthenia gravis was evaluated using severity and response to therapy rating scales and objective measures of hospital, intensive care, and intubation days, prethymectomy and postthymectomy, as markers of morbidity. Records of 50 patients treated...

  • Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in the Netherlands. Niks, Erik H.; Kuks, Jan B. M.; Verschuuren, Jan J. G. M. // Journal of Neurology, Neurosurgery & Psychiatry;Apr2007, Vol. 78 Issue 4, p417 

    The epidemiology of myasthenia gravis subtypes and the frequency of antibodies to muscle-specific kinase (MuSK) was studied in patients with generalised myasthenia gravis without anti-acetylcholine receptor antibodies who had an onset of symptoms between 1990 and 2004 in a well-defined region in...

  • Nilotinib.  // Reactions Weekly;Jul2014, Vol. 1509 Issue 1, p25 

    The article presents a case study of a 40-year-old man who developed generalised seropositive myasthenia gravis while being treated with nilotinib for chronic myeloid leukaemia.

  • Cyclophosphamide.  // Reactions Weekly;May2015, Vol. 1553 Issue 1, p109 

    The article presents case studies of 17 men and 5 women with generalised myasthenia gravis, who were treated with cyclophosphamide at a mean age of 41 years, and 13 of them developed various toxicities.


Read the Article


Sign out of this library

Other Topics